INFORMATION FOR
News
A new deep learning application provides an automated screening strategy for left ventricular (LV) systolic dysfunction. It can detect previously hidden conditions from electrocardiogram images.
In the United States, a significant number of patients continue to struggle with persistent hypertension.
Makoto Mori, MD, PhD, and Harlan Krumholz, MD, SM, used a digital platform to collect patient-reported outcomes data after cardiac surgery.
Adults who share a Hispanic background and who get hospitalized for symptoms of peripheral artery disease (PAD) are more likely to only receive care at later stages of their disease, and get their treatment through the emergency department instead of early stage disease care, elective care as compared with non-Hispanic white patients.
Sex is not a reliable indicator of the individual hemodynamic phenotype between women and men with high blood pressure, particularly older adults, a new Yale-led study concludes.
A new Yale-led study has for the first time identified which risk factors are more likely to trigger a heart attack or acute myocardial infarction (AMI) for men and women 55 years and younger.
Can we predict who will develop Alzheimer’s disease and other dementias? Can we identify biomarkers to predict disease development early? What are the most promising treatment targets?
A renewed interest in intravenous ascorbic acid, also known as vitamin C, could improve long-term success outcomes for patients undergoing solid-organ transplant.
Arya Mani MD, and colleagues have discovered a therapeutic target for the treatment of nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes.
New preliminary guidelines suggest that adults who may be prone to cardiovascular disease may benefit more from blood pressure management or statins than aspirin.
Dr. Samit Shah is leading a team to demonstrate the effectiveness of validated, but not widely administered procedures for the many women who have reduced blood flow to the heart without blocked arteries or cholesterol build-up often associated with heart disease.
Investigators at the Yale School of Medicine are participating in an international study to evaluate the clinical outcomes of TriClip, the first non-surgical minimally invasive tricuspid valve repair device developed by Abbott.
EuroPCR will be held May 18-20, 2021.
Trial to Examine the Clinical Impact of Risk Prediction in Heart Failure Underway at YNHH
A Yale-led group of doctors has developed a new mathematical model that can predict the risk of acute kidney injury (AKI) in patients undergoing a common heart procedure.
Krumholz was recognized “for his work as a founding leader in the field of outcomes research. His work has led to improvements in the quality of care and outcomes for millions of patients nationwide and beyond,” said American Heart Association President Robert A. Harrington, MD, FAHA.
A new Yale study shows that some patients being treated for severe heart failure with a battery-operated pump saw significant improvement after additionally using neurohormonal blockade (NHB) drug therapy.
A Yale co-authored study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best choice for initial treatment of hypertension.
Adult populations in the Caribbean, mirroring black populations in the U.S., experience higher rates of hypertension, stroke, and heart disease, and researchers want to know why.
Taking beta blockers — medications that reduce blood pressure and treat many heart conditions — can blunt the negative effects of stress and anger on people with a history of atrial fibrillation, or irregular heart rhythm, said Yale researchers. This strategy could potentially improve quality of life for many of the two million Americans with the condition, according to a new study.